Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01576120 · ClinicalTrials.gov registry record · Phase 1
Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients
A Phase 1 study of Crohn's Disease, sponsored by Medtronic - MITG.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT01576120: Completed Phase 1 study of Crohn's Disease, sponsored by Medtronic - MITG.
NCT01576120 is a Phase 1 study of Crohn's Disease that has completed, run by Medtronic - MITG. The registered enrollment target is 40 participants, below the 2,394-participant average among 105 other Crohn's Disease trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01576120, a Phase 1 study of Crohn's Disease, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The proposed study is designed to evaluate Pillcam regimen in Crohn's disease patients, using the PillCam Colon system.
Primary Outcome
effectiveness of the PillCam COLON 2 bowel prep regimen in Crohn's Disease patients will be evaluated by the folloiwng: • Bowel preparation cleansing level assessment The duration of the procedure in this study is 1 day of colon preparation and 1 day of Capsule Endoscopy (CE) procedure. 5-9 days after the CE procedure a follow up call to the subjects will be conducted.
Conditions Studied
Interventions
- OTHER bowel prep regimen first boost 6 oz. and second boost 3 oz.
- OTHER bowel prep regimen first boost 3 oz. and second boost 6 oz.
Study Locations (2)
Georgia
- Atlanta Gastroenterology Associates - Atlanta
Ohio
- Dayton Gastroenterology - Beavercreek
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
What the finished NCT01576120 record still lists
NCT01576120 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,394-participant average among 105 other Crohn's Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 2 interventions - of which bowel prep regimen first boost 6 oz. and second boost 3 oz. is the first listed.
NCT01576120 reports a single indexed study location in Georgia, Ohio.
Frequently Asked Questions
What is clinical trial NCT01576120 about?
NCT01576120 is a clinical study titled "Evaluation of a PillCam Colon Bowel Preparation Regimen in Crohn's Disease Patients". The proposed study is designed to evaluate Pillcam regimen in Crohn's disease patients, using the PillCam Colon system.
What is the current status of trial NCT01576120?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2012-03. Estimated completion is 2014-07.
What conditions does trial NCT01576120 study?
This clinical trial studies the following conditions: Crohn's Disease.
What interventions are being tested in trial NCT01576120?
The interventions under investigation include: bowel prep regimen first boost 6 oz. and second boost 3 oz. (OTHER), bowel prep regimen first boost 3 oz. and second boost 6 oz. (OTHER).
Who is sponsoring clinical trial NCT01576120?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01576120 being conducted?
This trial has 2 study locations across Georgia, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01576120's enrollment target sits among peer trials
40 86th of 105 higher than 18 of 105 other Crohn's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Autologous Stem Cell Transplantation for Crohn's Disease
RECRUITING · Phase 1
-
An Open-Label, Proof of Consent Study of Vorinostat for the Treatment of Mdoerate-to-Severe Crohn s Disease and Maintenance Therapy With Ustekinumab
RECRUITING · Phase 1
-
Beta-Hydroxybutyrate Feasibility Treating IBD
RECRUITING · Phase 1
-
Treatment of Moderate to Severe Refractory Crohn's Disease
RECRUITING · Phase 1
-
Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's Disease
ACTIVE NOT RECRUITING · Phase 1
-
Use of Oral Probiotics to Reduce Urinary Oxalate Excretion
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia